P2Y and P2U receptors differentially release intracellular Ca2+ via the phospholipase c/inositol 1,4,5-triphosphate pathway in astrocytes from the dorsal spinal cord

Neuroscience. 1998 Oct;86(3):913-23. doi: 10.1016/s0306-4522(98)00128-6.

Abstract

In astrocytes, raising intracellular Ca2+ concentration is a principal mechanism for transducing extracellular signals following activation of cell-surface receptors. Receptors that may be activated by purine nucleotides, P2 receptors, are known to be expressed by astrocytes from dorsal spinal cord; these astrocytes express two distinct subtypes of P2 receptor, P2Y and P2U. A main goal of the present study was to determine the intracellular signalling pathways mediating the Ca2+ responses produced by stimulating these receptors. Experiments were done using cultured astrocytes from rat dorsal spinal cord. Ca2+ responses were evoked by 2-methylthio-ATP or UTP, nucleotides previously shown to selectively activate P2Y and P2U receptors, respectively, in these cells. P2Y- and P2U-evoked Ca2+ responses were found not to depend upon extracellular Ca2+ and were blocked by thapsigargin, a Ca2+-ATPase inhibitor known to deplete inositol 1,4,5-triphosphate-sensitive Ca2+ stores. Intracellular application of the inositol 1,4,5-triphosphate-sensitive receptor antagonist, heparin, or of the G-protein inhibitor guanosine 5'-O-(2-thiodiphosphate), blocked the P2Y- and P2U-evoked Ca2+ responses. Moreover, the responses were prevented by the phospholipase C inhibitor, U-73122, but were unaffected by the inactive analogue, U-73343. These results indicate that P2Y and P2U receptors on dorsal spinal astrocytes are linked via G-protein coupling to release of intracellular Ca2+ via the phospholipase C/inositol 1,4,5-triphosphate pathway. When we assessed the releasable pools of intracellular Ca2+, by repeated agonist applications in zero extracellular Ca2+, we found that the pool accessed by activating P2U receptors was only a subpool of that accessed by activating P2Y receptors. This implies that there are separable inositol 1,4,5-triphosphate-releasable pools of Ca2+ in dorsal spinal astrocytes and that these may be differentially released by activating distinct metabotropic P2 receptors. This differential release of Ca2+ may be important for physiological as well as pathophysiological events occurring within the spinal cord.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine Triphosphate / analogs & derivatives
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Astrocytes / cytology
  • Astrocytes / drug effects
  • Astrocytes / physiology*
  • Calcium / metabolism*
  • Calcium Channels / chemistry
  • Calcium Channels / physiology
  • Cells, Cultured
  • Embryo, Mammalian
  • Estrenes / pharmacology
  • GTP-Binding Proteins / antagonists & inhibitors
  • Guanosine Diphosphate / analogs & derivatives
  • Guanosine Diphosphate / pharmacology
  • Heparin / analogs & derivatives
  • Heparin / pharmacology
  • Inositol 1,4,5-Trisphosphate / metabolism*
  • Inositol 1,4,5-Trisphosphate Receptors
  • Phosphodiesterase Inhibitors / pharmacology
  • Pyrrolidinones / pharmacology
  • Rats
  • Rats, Wistar
  • Receptors, Cytoplasmic and Nuclear / chemistry
  • Receptors, Cytoplasmic and Nuclear / physiology
  • Receptors, Purinergic P2 / physiology*
  • Receptors, Purinergic P2Y2
  • Signal Transduction
  • Spinal Cord / cytology
  • Spinal Cord / physiology*
  • Thionucleotides / pharmacology
  • Type C Phospholipases / metabolism*
  • Uridine Triphosphate / pharmacology

Substances

  • Calcium Channels
  • Estrenes
  • Inositol 1,4,5-Trisphosphate Receptors
  • P2ry2 protein, rat
  • Phosphodiesterase Inhibitors
  • Pyrrolidinones
  • Receptors, Cytoplasmic and Nuclear
  • Receptors, Purinergic P2
  • Receptors, Purinergic P2Y2
  • Thionucleotides
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • U 73343
  • Guanosine Diphosphate
  • guanosine 5'-O-(2-thiodiphosphate)
  • Inositol 1,4,5-Trisphosphate
  • Adenosine Triphosphate
  • Heparin
  • Type C Phospholipases
  • GTP-Binding Proteins
  • Calcium
  • Uridine Triphosphate
  • 2-methylthio-ATP